The mechanism through which a loss of perlecan expression in the GBM occurs in the setting of DN is currently unknown, but it is possible that elevated glucose mediated induction of TGF-β1 bio-activation may play an important role as observed in mesothelial cells [35]. Here, TGFB1 is linked to liver dysplastic nodule.